Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Intraocular Lymphoma × Procarbazine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lymphoma 27 Hodgkin Disease 18 Central Nervous System Neoplasms 16 Astrocytoma 11 Oligodendroglioma 10 Glioblastoma 9 Brain Neoplasms 9 Gliosarcoma 7 Glioma 6 Recurrence 5 Neurotoxicity Syndromes 3 Lymphoma, Non-Hodgkin 3 Lymphoma, Follicular 3 Lymphoma, AIDS-Related 2 Radiation Injuries 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Optic Nerve Glioma 1 Medulloblastoma 1 Lymphoma, Mantle-Cell 1 Lymphoma, Large-Cell, Immunoblastic 1 Lymphoma, Large B-Cell, Diffuse 1 Intraocular Lymphoma 1 Familial ependymoma 1 Ependymoma 1 Drug-Related Side Effects and Adverse Reactions 1 Burkitt Lymphoma 1 Ataxia Telangiectasia 1 Ataxia 1

Interventions

Rituximab 12 Cyclophosphamide 11 Peripheral Blood Stem Cell Transplantation 10 fludarabine phosphate 8 Filgrastim 8 Cyclosporine 8 Whole-Body Irradiation 7 Methotrexate 7 Etoposide 7 Mycophenolic Acid 6 Lenalidomide 6 Radiotherapy 5 Cytarabine 5 Tacrolimus 4 Dexamethasone 4 Antilymphocyte Serum 4 Vorinostat 3 Thiotepa 3 Melphalan 3 Granulocyte Colony-Stimulating Factor 3 Dasatinib 3 Carboplatin 3 Busulfan 3 Bortezomib 3 tanespimycin 2 pegfilgrastim 2 laromustine 2 ibrutinib 2 etoposide phosphate 2 entinostat 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00074191 2017-04-21

Protocol-A

OHSU Knight Cancer Institute

Phase 2 Completed

Lymphoma, Intraocular Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡